Poor prognosis in familial acute myeloid leukaemia with combined biallelic <i>CEBPA</i> mutations and downstream events affecting the <i>ATM</i>, <i>FLT3</i> and <i>CDX2</i> genes
Catherine Carmichael(Hudson Institute), Hamish S. Scott(South Australia Pathology), Ella Wilkins(Victorian Clinical Genetics Services), Marshall S. Horwitz(University of Washington), Christopher N Hahn(South Australia Pathology), Robert Escher(Walter and Eliza Hall Institute of Medical Research), Paul Vincent(Royal Prince Alfred Hospital), Terence P. Speed(University of California, Berkeley), Graham Young(Royal Prince Alfred Hospital), Henrik Bengtsson(University of California, San Francisco)
Cited by 19
Related Papers
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
|Pharmacological Reviews|2010|857